Utility of Survivin, BAP1, and Ki‑67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia
Affiliations: Department of Pathology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734‑8551, Japan, Department of Pathology and Clinical Pathology, Faculty of Veterinary Medicine, South Valley University, Qena 83523, Egypt, Department of Surgical Oncology, Research Center for Radiation Casualty Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734‑8551, Japan, Department of Internal Medicine, Okayama Rosai Hospital, Okayama 702‑8055, Japan
- Published online on: January 10, 2018 https://doi.org/10.3892/ol.2018.7765
- Pages: 3540-3547
Copyright: © Kushitani et al. This is an open access article distributed under the terms of Creative Commons Attribution License.